<DOC>
	<DOC>NCT00310557</DOC>
	<brief_summary>The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the renal arteries. The results will be compared to the results of MRI taken without Magnevist and with the results of your X-ray angiography.</brief_summary>
	<brief_title>MagnevistÂ® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries</brief_title>
	<detailed_description>This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of the trial.</detailed_description>
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<criteria>Has known or suspected renal artery disease Is scheduled for Xray angiography Has any contraindication to magnetic resonance imaging Is scheduled for any procedure before the Xray angiography Had previously had stents placed bilaterally in the region to be imaged</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>